Gennex Laboratories Limited (BOM:531739)
India flag India · Delayed Price · Currency is INR
10.38
-0.61 (-5.55%)
At close: Mar 9, 2026

Gennex Laboratories Company Description

Gennex Laboratories Limited manufactures and sells bulk drugs, intermediates, and biotech products.

The company offers Guaifenesin, an expectorant used as a mucolyte; Methocarbamol for skeletal muscle relaxant; Fexofenadine Hcl for treating antihistamines; Phenazopyridine Hcl for the treatment of urinary tract analgesic; Fluconazole for antifungals; Melitracen Hcl for treating tricyclic antidepressant; Sertraline Hcl, a selective serotonin reuptake inhibitor; Chlorphenesin and Mephenesin for muscle relaxant; and Allopurinol, a xanthine oxidase inhibitor.

It has operations in India, Algeria, Bangladesh, Barzil, Bolivia, Colombia, the Czech Republic, Egypt, El Salvador, Germany, Guatemala City, Mexico, Peru, Spain, Turkey, Thailand, the United Arab Emirates, and Vietnam.

Gennex Laboratories Limited was formerly known as Prudential Pharmaceuticals Limited and changed its name to Gennex Laboratories Limited in September 2007.

Gennex Laboratories Limited was incorporated in 1985 and is based in Hyderabad, India.

Gennex Laboratories Limited
Country India
Founded 1985
Industry Pharmaceutical Preparations
Employees 115
CEO Arihant Baid

Contact Details

Address:
Plot No. 144, Akash Ganga Complex
Hyderabad, 500073
India
Phone 91 40 6733 4400
Website gennexlab.com

Stock Details

Ticker Symbol 531739
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Arihant Baid Chief Executive Officer
Akkali Kumar Chief Financial Officer
K. V. L. Bhaswanth Chief Operating Officer